An Innovative Conversational Agent (Quitbot) for Smoking Cessation

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

PHASE3

Total Enrollment

1647 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-07-24

Study Completion Date

2026-05-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Pilot Trial of the First Conversational Agent for Smoking Cessation (QuitBot)

NCT03585231

Smoking Cessation

COMPLETED NA

SmartQuit Program for Smoking Cessation

NCT04510077

Cigarette Smoking-Related Carcinoma Tobacco-Related Carcinoma

COMPLETED NA

Trial of An Innovative Smartphone Intervention for Smoking Cessation

NCT02724462

Smoking

COMPLETED NA

Innovative Smartphone Application of a New Behavioral Method to Quit Smoking: Pilot Trial (Smart Quit)

NCT01812070

Smoking

COMPLETED NA

Smoking Cessation Smartphone App for Cancer Patients (Quit2Heal Study)

NCT03600038

Cancer Smoking

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

OUTLINE:

Participants are randomized to 1 of 2 groups. Both groups receive access to a 42-day quit smoking program.

GROUP I: Experimental program, for 42 days to support quitting smoking. After the completion of study, patients are followed up at 3, 6, and 12 months.

GROUP II: Control program, for 42 days to support quitting smoking. After the completion of study, patients are followed up at 3, 6, and 12 months.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cigarette Smoking-Related Carcinoma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Group I (QuitBot Experimental)

Participants participate in the Quitbot program for 42 days to support quitting smoking. Therapy description withheld to protect the integrity of the study.

Group Type EXPERIMENTAL

Experimental Smoking Cessation Program

Intervention Type OTHER

Participate in Quitbot experimental cessation program

Group II (QuitBot Control)

Participants participate in the Quitbot program for 42 days to support quitting smoking. Therapy description withheld to protect the integrity of the study.

Group Type ACTIVE_COMPARATOR

Control Smoking Cessation Program

Intervention Type OTHER

Participate in Quitbot control cessation program

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Experimental Smoking Cessation Program

Participate in Quitbot experimental cessation program

Intervention Type OTHER

Control Smoking Cessation Program

Participate in Quitbot control cessation program

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Experimental Control

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 18 or older
* Smokes at least one cigarette a day for the past 12 months
* Wants to quit cigarette smoking within the next 30 days (consistent with text messaging intervention trials)
* If concurrently using any other nicotine or tobacco products, wants to quit using them within the next 30 days
* Interested in learning skills to quit smoking
* Willing to be randomly assigned to either intervention
* Resides in United States (US) and will continue to reside in the US for the next 12 months
* Has at least daily access to their own smartphone
* Has text messaging on their smartphone and knows how to download a smartphone application
* Willing and able to read in English, and
* Not using other smoking cessation interventions (This eligibility requirement helps ensure results are due to the treatments we recommend rather than those that participants are doing on their own.)

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes